All products are sold strictly for research and laboratory use only
In a 68- and 72-week clinical trial studying Wegovy (2.4 mg), brand-name Semaglutide, and Zepbound (15 mg), brand-name Tirzepatide, in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20% respectively, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)
Lassen, N
Take those statistics with appropriate skepticism
Novo Nordisk stands behind the safety and efficacy of all its GLP-1 medicines when theyre used as indicated and taken under the care of a licensed health care professional, it says in a statement to TODAY.com
It facilitates online medical intake, clinician review, and pharmacy fulfillment